Business is booming for the maker of specialty digital mammography and x-ray imaging systems. In its second quarter, end July 1, the company reported revenue up $900,000 to $12.8 million compared with $11.9 million for the same quarter last year. Net
Business is booming for the maker of specialty digital mammography and x-ray imaging systems. In its second quarter, end July 1, the company reported revenue up $900,000 to $12.8 million compared with $11.9 million for the same quarter last year. Net income for the quarter was $751,000, or 9¢ per share, compared with $465,000, or 7¢ per share, for the same period last year. For the six months ended July 1, net income increased by 18% to $958,000, compared with a net income of $815,000 for the same period last year, reflecting a third-quarter 2000 one million share equity placement. CFO Rodney B. Johnson credited a streamlining of production processes and reorganization of the sales force for the improved bottom line.
FDA Clears Updated AI Platform for Digital Breast Tomosynthesis
November 12th 2024Employing advanced deep learning convolutional neural networks, ProFound Detection Version 4.0 reportedly offers a 50 percent improvement in detecting cancer in dense breasts in comparison to the previous version of the software.
Is the Kaiser Score More Effective than BI-RADS for Assessing Contrast-Enhanced Mammography and MRI?
October 14th 2024For women with breast-enhanced masses, Kaiser scoring (KS) demonstrated a 20 percent higher AUC than BI-RADS classification for contrast-enhanced mammography (CEM) and was comparable to KS for breast MRI.
FDA Clears New Features in AI-Powered Mammography Software Suite
October 11th 2024Therapixel’s MammoScreen suite has received 510(k) FDA clearances for a breast density assessment feature and updated software that includes automated pre-reporting, which reportedly expedites reporting of mammography findings.